scholarly article | Q13442814 |
P2093 | author name string | Richard P Wenzel | |
Chris Gennings | |||
P2860 | cites work | Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients | Q28362691 |
Choice of effect measure for epidemiological data | Q30614196 | ||
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients | Q34273626 | ||
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting | Q34509624 | ||
Attributable mortality of nosocomial candidemia, revisited | Q44386169 | ||
Nosocomial bloodstream infections in United States hospitals: a three-year analysis | Q44863798 | ||
Perspective: Attributable mortality--the promise of better antimicrobial therapy | Q45113430 | ||
Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections | Q45259096 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
intensive care unit | Q5094647 | ||
P304 | page(s) | S389-93 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies | |
P478 | volume | 41 Suppl 6 |